- Home
- STT vs DXCM Comparison
STT vs DXCM Comparison
Compare STT & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STT
- DXCM
- Stock Information
- Founded
- STT 1792
- DXCM 1999
- Country
- STT United States
- DXCM United States
- Employees
- STT N/A
- DXCM N/A
- Industry
- STT Major Banks
- DXCM Medical/Dental Instruments
- Sector
- STT Finance
- DXCM Health Care
- Exchange
- STT Nasdaq
- DXCM Nasdaq
- Market Cap
- STT 25.8B
- DXCM 34.1B
- IPO Year
- STT N/A
- DXCM 2005
- Fundamental
- Price
- STT $109.35
- DXCM $83.52
- Analyst Decision
- STT Buy
- DXCM Strong Buy
- Analyst Count
- STT 12
- DXCM 20
- Target Price
- STT $113.00
- DXCM $98.50
- AVG Volume (30 Days)
- STT 2.1M
- DXCM 3.8M
- Earning Date
- STT 07-15-2025
- DXCM 07-30-2025
- Dividend Yield
- STT 2.77%
- DXCM N/A
- EPS Growth
- STT 64.15
- DXCM N/A
- EPS
- STT 8.90
- DXCM 1.33
- Revenue
- STT $13,086,000,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- STT $4.72
- DXCM $16.74
- Revenue Next Year
- STT $3.25
- DXCM $15.29
- P/E Ratio
- STT $12.32
- DXCM $62.58
- Revenue Growth
- STT 9.48
- DXCM 9.11
- 52 Week Low
- STT $72.81
- DXCM $57.52
- 52 Week High
- STT $110.97
- DXCM $117.19
- Technical
- Relative Strength Index (RSI)
- STT 72.47
- DXCM 49.26
- Support Level
- STT $108.83
- DXCM $82.73
- Resistance Level
- STT $110.93
- DXCM $85.92
- Average True Range (ATR)
- STT 1.89
- DXCM 2.63
- MACD
- STT 0.24
- DXCM -0.09
- Stochastic Oscillator
- STT 86.47
- DXCM 54.33
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $47 trillion in assets under custody and administration and $4.7 trillion assets under management as of Dec. 31, 2024, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.